Sign in

CIK 0001937653

  • Non-accelerated filer
  • Smaller reporting company

Zymeworks Inc.

Sign in to watch
Ticker
ZYME
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
883099146
Phone
+1 302-274-8744
Business address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Former names
Zymeworks Delaware Inc.
  1. 4 Open-market buy Director bought 97,349 shares at an average $12.61 ($1,227,309)
  2. 4 Open-market buy Director bought 127,198 shares at an average $12.92 ($1,643,248)
  3. 4 Open-market buy Director bought 228,463 shares at an average $12.55 ($2,866,553)
  4. 4 Open-market buy Director bought 1,081,980 shares at an average $12.13 ($13,120,914)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Open-market buy Director bought 141,429 shares at an average $13.88 ($1,963,538)
  7. 4 Open-market buy Director bought 167,654 shares at an average $13.59 ($2,278,811)
  8. 4 Open-market buy Director bought 225,119 shares at an average $13.21 ($2,974,819)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Chief Scientific Officer sold 21,200 shares at $14.92 ($316,391)
  14. 4 Open-market sale Chair & CEO sold 57,291 shares at $14.92 ($855,017)
  15. 4 Open-market sale EVP & Chief Medical Officer sold 11,110 shares at $14.92 ($165,807)
  16. 4 Open-market buy Director bought 363,369 shares at an average $14.64 ($5,321,176)
  17. 4 Open-market buy Director bought 130,309 shares at an average $14.44 ($1,882,115)
  18. 4/A Open-market buy Director bought 1,254,808 shares at an average $13.98 ($17,544,284)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 7 · 121 filings